Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VNRX - The Prognosis For VolitionRx


VNRX - The Prognosis For VolitionRx

  • VolitionRx is now a commercial concern with the beta launch of its dog cancer blood tests in Texas commencing 4Q20.
  • The company’s unique epigenetic approach to testing has the potential to detect cancer earlier and should have applications in many other disease types.
  • With a national launch of its veterinary cancer test in 2021 and insider buying, Volition merited further investigation.

For further details see:

The Prognosis For VolitionRx
Stock Information

Company Name: VolitionRX Limited
Stock Symbol: VNRX
Market: NYSE
Website: volition.com

Menu

VNRX VNRX Quote VNRX Short VNRX News VNRX Articles VNRX Message Board
Get VNRX Alerts

News, Short Squeeze, Breakout and More Instantly...